title: "Normalization" of brain activation in schizophrenia. An fMRI study.
authors.forename: A
authors.initials: A
authors.lastname: Lund
authors.forename: R
authors.initials: R
authors.lastname: Kroken
authors.forename: T
authors.initials: T
authors.lastname: Thomsen
authors.forename: K
authors.initials: K
authors.lastname: Hugdahl
authors.forename: A I
authors.initials: AI
authors.lastname: Smievoll
authors.forename: R
authors.initials: R
authors.lastname: Barndon
authors.forename: J
authors.initials: J
authors.lastname: Iversen
authors.forename: N I
authors.initials: NI
authors.lastname: Landrø
authors.forename: K
authors.initials: K
authors.lastname: Sundet
authors.forename: B R
authors.initials: BR
authors.lastname: Rund
authors.forename: L
authors.initials: L
authors.lastname: Ersland
authors.forename: A
authors.initials: A
authors.lastname: Lundervold
authors.forename: A
authors.initials: A
authors.lastname: Asbjørnsen
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines; D001921:Brain / Q000473:pathology* / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D000077152:Olanzapine